Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
Acta Pharmacologica Sinica
|
December 11, 2021
Fibrinolytic therapy for COVID-19: a review of case series
Hong-Long Ji, Yuling Dai, Runzhen Zhao
Oncotarget
|
April 22, 2017
Serious adverse events of cell therapy for respiratory diseases: a systematic review and meta-analysis
Runzhen Zhao, Zhenlei Su, Jing Wu, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
April 18, 2025
Transgenically expressed human delta epithelial sodium channel facilitated fluid absorption in mouse fetal lung explants
Krishan G Jain, Runzhen Zhao, Jiwang Zhang, et al.
Physiological Reviews
|
March 29, 2020
Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility
Hong-Long Ji, Runzhen Zhao, Sadis Matalon, et al.
Scientific Reports
|
February 28, 2025
Semantic structure preservation for accurate multi-modal glioma diagnosis
Chaoyu Shi, Xia Zhang, Runzhen Zhao, et al.
Scientific Reports
|
August 5, 2016
Systematic review and meta-analysis of nasal potential difference in hypoxia-induced lung injury
Zhenlei Su, Lili Zhu, Jing Wu, et al.
Pulmonary Pharmacology & Therapeutics
|
July 16, 2021
Fibrinolytic or anti-plasmin (nafamostat) therapy for COVID-19: A timing challenge for clinicians
Hong-Long Ji, Brant M Wagener, Timothy J Ness, et al.
Stem Cell Research & Therapy
|
March 22, 2022
Prkg2 regulates alveolar type 2-mediated re-alveolarization
Mo Zhang, Gibran Ali, Satoshi Komatsu, et al.
Cell Biology and Toxicology
|
June 27, 2020
Ion transport mechanisms for smoke inhalation-injured airway epithelial barrier
Jianjun Chang, Zaixing Chen, Runzhen Zhao, et al.
Research Square
|
March 13, 2023
PAI-1 regulates AT2-mediated re-alveolarization and ion permeability
Gibran Ali, Mo Zhang, Jianjun Chang, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
Acta Pharmacologica Sinica
|
December 11, 2021
Fibrinolytic therapy for COVID-19: a review of case series
Hong-Long Ji, Yuling Dai, Runzhen Zhao
Oncotarget
|
April 22, 2017
Serious adverse events of cell therapy for respiratory diseases: a systematic review and meta-analysis
Runzhen Zhao, Zhenlei Su, Jing Wu, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
April 18, 2025
Transgenically expressed human delta epithelial sodium channel facilitated fluid absorption in mouse fetal lung explants
Krishan G Jain, Runzhen Zhao, Jiwang Zhang, et al.
Physiological Reviews
|
March 29, 2020
Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility
Hong-Long Ji, Runzhen Zhao, Sadis Matalon, et al.
Scientific Reports
|
February 28, 2025
Semantic structure preservation for accurate multi-modal glioma diagnosis
Chaoyu Shi, Xia Zhang, Runzhen Zhao, et al.
Scientific Reports
|
August 5, 2016
Systematic review and meta-analysis of nasal potential difference in hypoxia-induced lung injury
Zhenlei Su, Lili Zhu, Jing Wu, et al.
Pulmonary Pharmacology & Therapeutics
|
July 16, 2021
Fibrinolytic or anti-plasmin (nafamostat) therapy for COVID-19: A timing challenge for clinicians
Hong-Long Ji, Brant M Wagener, Timothy J Ness, et al.
Stem Cell Research & Therapy
|
March 22, 2022
Prkg2 regulates alveolar type 2-mediated re-alveolarization
Mo Zhang, Gibran Ali, Satoshi Komatsu, et al.
Cell Biology and Toxicology
|
June 27, 2020
Ion transport mechanisms for smoke inhalation-injured airway epithelial barrier
Jianjun Chang, Zaixing Chen, Runzhen Zhao, et al.
Research Square
|
March 13, 2023
PAI-1 regulates AT2-mediated re-alveolarization and ion permeability
Gibran Ali, Mo Zhang, Jianjun Chang, et al.
Page
of 4